Veraxa Biotech AG Statistics
Total Valuation
VRXA has a market cap or net worth of $161.20 million. The enterprise value is $160.61 million.
| Market Cap | 161.20M |
| Enterprise Value | 160.61M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
VRXA has 141.41 million shares outstanding.
| Current Share Class | 141.41M |
| Shares Outstanding | 141.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 41.48% |
| Owned by Institutions (%) | 0.46% |
| Float | 36.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5,456.62 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5,436.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.44
| Current Ratio | 0.44 |
| Quick Ratio | 0.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18,644.03 |
Financial Efficiency
Return on equity (ROE) is -871.42% and return on invested capital (ROIC) is -478.61%.
| Return on Equity (ROE) | -871.42% |
| Return on Assets (ROA) | -49.99% |
| Return on Invested Capital (ROIC) | -478.61% |
| Return on Capital Employed (ROCE) | -89.23% |
| Weighted Average Cost of Capital (WACC) | 5.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -495,117 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.83% in the last 52 weeks. The beta is 0.19, so VRXA's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -88.83% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 7.64 |
| Relative Strength Index (RSI) | 38.90 |
| Average Volume (20 Days) | 216,778 |
Short Selling Information
The latest short interest is 235,019, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 235,019 |
| Short Previous Month | 209,727 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.64% |
| Short Ratio (days to cover) | 0.76 |
Income Statement
In the last 12 months, VRXA had revenue of $29,543 and -$84.01 million in losses. Loss per share was -$5.80.
| Revenue | 29,543 |
| Gross Profit | 19,498 |
| Operating Income | -83.51M |
| Pretax Income | -84.50M |
| Net Income | -84.01M |
| EBITDA | -81.02M |
| EBIT | -83.51M |
| Loss Per Share | -$5.80 |
Balance Sheet
The company has $2.04 million in cash and $1.44 million in debt, with a net cash position of $596,937 or $0.00 per share.
| Cash & Cash Equivalents | 2.04M |
| Total Debt | 1.44M |
| Net Cash | 596,937 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | -19.88M |
| Book Value Per Share | -1.35 |
| Working Capital | -4.70M |
Cash Flow
In the last 12 months, operating cash flow was -$11.86 million and capital expenditures -$523,726, giving a free cash flow of -$12.39 million.
| Operating Cash Flow | -11.86M |
| Capital Expenditures | -523,726 |
| Depreciation & Amortization | 2.36M |
| Net Borrowing | 1.00M |
| Free Cash Flow | -12.39M |
| FCF Per Share | -$0.09 |
Margins
| Gross Margin | 66.00% |
| Operating Margin | -282,661.28% |
| Pretax Margin | -286,033.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRXA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -52.11% |
| FCF Yield | -7.68% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VRXA has an Altman Z-Score of -2.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.78 |
| Piotroski F-Score | 1 |